ZA200707910B - Contraceptive pharmaceutical preparation - Google Patents

Contraceptive pharmaceutical preparation

Info

Publication number
ZA200707910B
ZA200707910B ZA200707910A ZA200707910A ZA200707910B ZA 200707910 B ZA200707910 B ZA 200707910B ZA 200707910 A ZA200707910 A ZA 200707910A ZA 200707910 A ZA200707910 A ZA 200707910A ZA 200707910 B ZA200707910 B ZA 200707910B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical preparation
contraceptive pharmaceutical
contraceptive
preparation
pharmaceutical
Prior art date
Application number
ZA200707910A
Inventor
Graeser Thomas
Claussen Claus
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of ZA200707910B publication Critical patent/ZA200707910B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
ZA200707910A 2005-02-15 2007-09-14 Contraceptive pharmaceutical preparation ZA200707910B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05003179A EP1690543A1 (en) 2005-02-15 2005-02-15 Pharmaceutical composition for contraception

Publications (1)

Publication Number Publication Date
ZA200707910B true ZA200707910B (en) 2009-08-26

Family

ID=34933759

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200707910A ZA200707910B (en) 2005-02-15 2007-09-14 Contraceptive pharmaceutical preparation

Country Status (20)

Country Link
EP (2) EP1690543A1 (en)
JP (1) JP2008527018A (en)
KR (1) KR20070086380A (en)
CN (1) CN101119732A (en)
AR (1) AR053545A1 (en)
AU (1) AU2006215818A1 (en)
BR (1) BRPI0606724A2 (en)
CA (1) CA2590004A1 (en)
CR (1) CR9324A (en)
DO (1) DOP2006000035A (en)
EA (1) EA200701091A1 (en)
IL (1) IL183635A0 (en)
MX (1) MX2007009061A (en)
NO (1) NO20072687L (en)
PA (1) PA8663401A1 (en)
PE (1) PE20061291A1 (en)
TW (1) TW200640468A (en)
UA (1) UA85003C2 (en)
WO (1) WO2006087173A1 (en)
ZA (1) ZA200707910B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1774970A1 (en) * 2005-10-13 2007-04-18 Bayer Schering Pharma AG Method for preparing a monophase pharnmaceutical preparation containing ethinyl estradiol and dienogest for the treatment of dysfunctional uterine bleeding
EP2209475A2 (en) * 2007-10-11 2010-07-28 Bayer Schering Pharma Aktiengesellschaft Process for producing a monophasic pharmaceutical product for limiting/reducing the risk of deep vein thrombosis united with oral contraception
DE202007019049U1 (en) * 2007-11-05 2010-05-12 Bayer Schering Pharma Aktiengesellschaft Use of a gestagen in combination with an estrogen for the prophylaxis of lactose intolerance in oral contraception

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE271386T1 (en) * 1996-07-26 2004-08-15 Wyeth Corp ORAL SINGLE STAGE CONTRACEPTION METHOD AND COMBINATION PRODUCT CONTAINING PROGESTEN AND ESTROGEN

Also Published As

Publication number Publication date
BRPI0606724A2 (en) 2009-07-14
KR20070086380A (en) 2007-08-27
EA200701091A1 (en) 2008-02-28
MX2007009061A (en) 2007-09-11
PE20061291A1 (en) 2006-12-07
IL183635A0 (en) 2007-10-31
AR053545A1 (en) 2007-05-09
WO2006087173A1 (en) 2006-08-24
TW200640468A (en) 2006-12-01
CR9324A (en) 2007-10-11
NO20072687L (en) 2007-11-13
PA8663401A1 (en) 2006-12-07
EP1853273A1 (en) 2007-11-14
JP2008527018A (en) 2008-07-24
CN101119732A (en) 2008-02-06
DOP2006000035A (en) 2006-09-15
CA2590004A1 (en) 2006-08-24
UA85003C2 (en) 2008-12-10
AU2006215818A1 (en) 2006-08-24
EP1690543A1 (en) 2006-08-16

Similar Documents

Publication Publication Date Title
IL177566A0 (en) Pharmaceutical formulations
HK1125295A1 (en) Microtablet-based pharmaceutical preparation
IL185390A (en) Solid pharmaceutical dosage formulation
PL1957073T3 (en) Medicinal drug
ZA200705530B (en) Sustained release pharmaceutical formulations
AP2008004533A0 (en) Pharmaceutical combination
GB0426301D0 (en) Pharmaceutical formulations
GB0419849D0 (en) Pharmaceutical combination
IL185197A0 (en) Ophthalmological pharmaceutical compositions
ZA200803152B (en) Oramucosal pharmaceutical dosage form
EP2002828A4 (en) Solid pharmaceutical preparation
HU0401177D0 (en) Pharmaceutical composition
GB0416397D0 (en) Pharmaceutical formulations
GB2411355B (en) Pharmaceutical composition
GB0423800D0 (en) New pharmaceutical formulations
IL198160A0 (en) Pharmaceutical formulations
HK1105358A1 (en) Solid pharmaceutical formulation
ZA200804666B (en) Pharmaceutical combination
ZA200707910B (en) Contraceptive pharmaceutical preparation
GB0425255D0 (en) Pharmaceutical composition
GB0406048D0 (en) Drug formulations
EP1864664A4 (en) Pharmaceutical preparation
EP1716865A4 (en) Paraoxonase-containing pharmaceutical preparation
GB0417777D0 (en) Pharmaceutical combination
GB0402799D0 (en) Pharmaceutical composition